Short on Competition Act
Sens. Klobuchar and Lee Introduce Bipartisan Bill to Allow Drug Imports During Shortages
The Short on Competition Act is currently in the early stages of the legislative process. It was recently introduced and sent to the Senate Committee on Health, Education, Labor, and Pensions for review. The bill is actively moving as it waits for the committee to decide on its next steps.
Legislative Progress
This bill has rare, high-level support from both Democrats and Republicans, but it faces strong opposition from the drug industry.
Key Points
Impact Analysis
Personal Impact
Life & Work
Independent pharmacies and small drug distributors could benefit from a more stable supply chain and new sourcing options when drug shortages make it hard to stock essential medications. Additional importation channels may reduce the pricing power of dominant manufacturers in concentrated markets.
Programs
Disabilities
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Short on Competition Act
Data Sources
Sponsor
Cosponsors
(3)Analysis generated by AI. Always verify with official sources.